EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia

Vasiliki Karpa, Kallirhoe Kalinderi, Liana Fidani, Athanasios Tragiannidis iD

Hematology Reports · 20.11.2023 · 15 (4) · 634-650

DOI: 10.3390/hematolrep15040065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology Reports, online erschienen am 20.11.2023. Verfasst von Vasiliki Karpa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Biology-Genetics, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate (MTX), a structurally related substance to folic acid, is an important chemotherapeutic agent used for decades in the treatment of pediatric acute lymphoblastic leukemia (ALL) and other types of cancer as non-Hodgkin lymphomas and osteosarcomas. Despite the successful outcomes observed, the primary drawback is the variability in the pharmacokinetics and pharmacodynamics between patients. The main adverse events related to its use are nephrotoxicity, mucositis, and myelosuppression, especially when used in high doses. The potential adverse reactions and toxicities associated with MTX are a cause for concern and may lead to dose reduction or treatment interruption. Genetic variants in MTX transport genes have been linked to toxicity. Pharmacogenetic studies conducted in the past focused on single nucleotide polymorphisms (SNPs) in the coding and 5′-regulatory regions of genes. Recent studies have demonstrated a significant role of microRNAs (miRNAs) in the transport and metabolism of drugs and in the regulation of target genes. In the last few years, the number of annotated miRNAs has continually risen, in addition to the studies of miRNA polymorphisms and MTX toxicity. Therefore, the objective of the present study is to investigate the role of miRNA variants related to MTX adverse effects.

Schlagwörter

Stichwörter der Autor:innen

acute lymphoblastic leukemiamethotrexatemicroRNAspediatricpharmacogeneticstoxicity

Autor:innen und Institutionen

  • Laboratory of Medical Biology-Genetics, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Pediatric & Adolescent Hematology-Oncology Unit, 2nd Pediatric Department, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA Hospital, S. Kiriakidi 1, 54636 Thessaloniki, Greece.

ORCID-Profile: Athanasios Tragiannidis

Zitieren

APA

Karpa, V., Kalinderi, K., Fidani, L., & Tragiannidis, A. (2023). Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia. Hematology Reports, 15(4), 634-650. https://doi.org/10.3390/hematolrep15040065

Vancouver

Karpa V, Kalinderi K, Fidani L, Tragiannidis A. Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia. Hematology Reports. 2023;15(4):634-650. doi:10.3390/hematolrep15040065

BibTeX
@article{Karpa2023,
  author = {Karpa, Vasiliki and Kalinderi, Kallirhoe and Fidani, Liana and Tragiannidis, Athanasios},
  title = {Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia},
  journal = {Hematology Reports},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {634--650},
  doi = {10.3390/hematolrep15040065}
}
Kostenlos starten →